Living with IgG4-related disease often feels like navigating a world that was not built for me. Like many, I know what it means to search for answers, face uncertainty, experience delays in diagnosis, struggle with insurance barriers, and repeatedly explain a disease that few people have ever heard of.
Discussion
Obexelimab, an investigational therapy for people with immunoglobulin G4-related disease (IgG4-RD), was found to reduce disease activity among participants in an IgG4-RD clinical study without eliminating the benefits of vaccination against flu and COVID-19, according to new data. Additional results from other analyses showed obexelimab can lessen the need…
Discussion
I recently attended a free webinar called “Prevail: Creating Your Path Forward with IgG4-RD,” sponsored by the pharmaceutical company Amgen. The speaker was rheumatologist Brittany Panico. What resonated with me most from her presentation was the variety of organs that are commonly affected by the disorder, the range of…
Get regular updates to your inbox.
